Bill Text: FL S0700 | 2024 | Regular Session | Introduced


Bill Title: Controlled Substances

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2024-03-08 - Died in Judiciary [S0700 Detail]

Download: Florida-2024-S0700-Introduced.html
       Florida Senate - 2024                                     SB 700
       
       
        
       By Senator Gruters
       
       
       
       
       
       22-00740-24                                            2024700__
    1                        A bill to be entitled                      
    2         An act relating to controlled substances; amending s.
    3         893.03, F.S.; excepting from the list of Schedule I
    4         controlled substances certain xylazine animal drug
    5         products approved by the United States Food and Drug
    6         Administration and used for certain purposes;
    7         providing applicability; providing an effective date.
    8          
    9  Be It Enacted by the Legislature of the State of Florida:
   10  
   11         Section 1. Paragraph (c) of subsection (1) of section
   12  893.03, Florida Statutes, is amended to read:
   13         893.03 Standards and schedules.—The substances enumerated
   14  in this section are controlled by this chapter. The controlled
   15  substances listed or to be listed in Schedules I, II, III, IV,
   16  and V are included by whatever official, common, usual,
   17  chemical, trade name, or class designated. The provisions of
   18  this section shall not be construed to include within any of the
   19  schedules contained in this section any excluded drugs listed
   20  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   21  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   22  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   23  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   24  Anabolic Steroid Products.”
   25         (1) SCHEDULE I.—A substance in Schedule I has a high
   26  potential for abuse and has no currently accepted medical use in
   27  treatment in the United States and in its use under medical
   28  supervision does not meet accepted safety standards. The
   29  following substances are controlled in Schedule I:
   30         (c) Unless specifically excepted or unless listed in
   31  another schedule, any material, compound, mixture, or
   32  preparation that contains any quantity of the following
   33  hallucinogenic substances or that contains any of their salts,
   34  isomers, including optical, positional, or geometric isomers,
   35  homologues, nitrogen-heterocyclic analogs, esters, ethers, and
   36  salts of isomers, homologues, nitrogen-heterocyclic analogs,
   37  esters, or ethers, if the existence of such salts, isomers, and
   38  salts of isomers is possible within the specific chemical
   39  designation or class description:
   40         1. Alpha-Ethyltryptamine.
   41         2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
   42  oxazoline).
   43         3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
   44         4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
   45         5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
   46         6. Bufotenine.
   47         7. Cannabis.
   48         8. Cathinone.
   49         9. DET (Diethyltryptamine).
   50         10. 2,5-Dimethoxyamphetamine.
   51         11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
   52         12. DMT (Dimethyltryptamine).
   53         13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
   54  analog of phencyclidine).
   55         14. JB-318 (N-Ethyl-3-piperidyl benzilate).
   56         15. N-Ethylamphetamine.
   57         16. Fenethylline.
   58         17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
   59         18. Ibogaine.
   60         19. LSD (Lysergic acid diethylamide).
   61         20. Mescaline.
   62         21. Methcathinone.
   63         22. 5-Methoxy-3,4-methylenedioxyamphetamine.
   64         23. PMA (4-Methoxyamphetamine).
   65         24. PMMA (4-Methoxymethamphetamine).
   66         25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
   67         26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
   68         27. MDA (3,4-Methylenedioxyamphetamine).
   69         28. JB-336 (N-Methyl-3-piperidyl benzilate).
   70         29. N,N-Dimethylamphetamine.
   71         30. Parahexyl.
   72         31. Peyote.
   73         32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
   74  analog of phencyclidine).
   75         33. Psilocybin.
   76         34. Psilocyn.
   77         35. Salvia divinorum, except for any drug product approved
   78  by the United States Food and Drug Administration which contains
   79  Salvia divinorum or its isomers, esters, ethers, salts, and
   80  salts of isomers, esters, and ethers, if the existence of such
   81  isomers, esters, ethers, and salts is possible within the
   82  specific chemical designation.
   83         36. Salvinorin A, except for any drug product approved by
   84  the United States Food and Drug Administration which contains
   85  Salvinorin A or its isomers, esters, ethers, salts, and salts of
   86  isomers, esters, and ethers, if the existence of such isomers,
   87  esters, ethers, and salts is possible within the specific
   88  chemical designation.
   89         37. Xylazine, except for a xylazine animal drug product
   90  approved by the United States Food and Drug Administration and
   91  the use of which conforms to the approved application or is
   92  authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
   93  importation, distribution, prescribing, or sale of xylazine for
   94  human use is not subject to this exception.
   95         38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
   96  (Thiophene analog of phencyclidine).
   97         39. 3,4,5-Trimethoxyamphetamine.
   98         40. Methylone (3,4-Methylenedioxymethcathinone).
   99         41. MDPV (3,4-Methylenedioxypyrovalerone).
  100         42. Methylmethcathinone.
  101         43. Methoxymethcathinone.
  102         44. Fluoromethcathinone.
  103         45. Methylethcathinone.
  104         46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  105  yl)phenol) and its dimethyloctyl (C8) homologue.
  106         47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
  107  methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
  108         48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  109         49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  110         50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  111  naphthoyl)indole).
  112         51. BZP (Benzylpiperazine).
  113         52. Fluorophenylpiperazine.
  114         53. Methylphenylpiperazine.
  115         54. Chlorophenylpiperazine.
  116         55. Methoxyphenylpiperazine.
  117         56. DBZP (1,4-Dibenzylpiperazine).
  118         57. TFMPP (Trifluoromethylphenylpiperazine).
  119         58. MBDB (Methylbenzodioxolylbutanamine) or (3,4
  120  Methylenedioxy-N-methylbutanamine).
  121         59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  122         60. 5-Hydroxy-N-methyltryptamine.
  123         61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  124         62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  125         63. Methyltryptamine.
  126         64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  127         65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  128         66. Tyramine (4-Hydroxyphenethylamine).
  129         67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  130         68. DiPT (N,N-Diisopropyltryptamine).
  131         69. DPT (N,N-Dipropyltryptamine).
  132         70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  133         71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  134         72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  135         73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  136         74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  137         75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  138         76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  139         77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  140         78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  141         79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  142         80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  143         81. Butylone (3,4-Methylenedioxy-alpha
  144  methylaminobutyrophenone).
  145         82. Ethcathinone.
  146         83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
  147         84. Naphyrone (Naphthylpyrovalerone).
  148         85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
  149         86. 3,4-Methylenedioxy-N,N-diethylcathinone.
  150         87. 3,4-Methylenedioxy-propiophenone.
  151         88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
  152         89. 3,4-Methylenedioxy-propiophenone-2-oxime.
  153         90. 3,4-Methylenedioxy-N-acetylcathinone.
  154         91. 3,4-Methylenedioxy-N-acetylmethcathinone.
  155         92. 3,4-Methylenedioxy-N-acetylethcathinone.
  156         93. Bromomethcathinone.
  157         94. Buphedrone (alpha-Methylamino-butyrophenone).
  158         95. Eutylone (3,4-Methylenedioxy-alpha
  159  ethylaminobutyrophenone).
  160         96. Dimethylcathinone.
  161         97. Dimethylmethcathinone.
  162         98. Pentylone (3,4-Methylenedioxy-alpha
  163  methylaminovalerophenone).
  164         99. MDPPP (3,4-Methylenedioxy-alpha
  165  pyrrolidinopropiophenone).
  166         100. MDPBP (3,4-Methylenedioxy-alpha
  167  pyrrolidinobutyrophenone).
  168         101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  169         102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
  170         103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  171  (Benocyclidine).
  172         104. F-MABP (Fluoromethylaminobutyrophenone).
  173         105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
  174         106. Et-PBP (Ethylpyrrolidinobutyrophenone).
  175         107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  176         108. Me-EABP (Methylethylaminobutyrophenone).
  177         109. Etizolam.
  178         110. PPP (Pyrrolidinopropiophenone).
  179         111. PBP (Pyrrolidinobutyrophenone).
  180         112. PVP (Pyrrolidinovalerophenone) or
  181  (Pyrrolidinopentiophenone).
  182         113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
  183         114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  184         115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  185         116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  186         117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  187         118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  188         119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  189         120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  190         121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  191  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  192         122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  193         123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  194         124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  195         125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  196         126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  197         127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  198         128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  199         129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  200         130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  201  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  202  ol).
  203         131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
  204  2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
  205  methanol).
  206         132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
  207  methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
  208  1,4-dione).
  209         133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
  210         134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
  211  undecanamide).
  212         135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
  213  undecanamide).
  214         136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
  215  methyloctan-2-yl)phenol).
  216         137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  217         138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
  218         139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  219         140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2
  220  methoxyphenylacetyl)indole).
  221         141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
  222  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  223  naphthalenylmethanone).
  224         142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
  225  morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
  226  naphthalenylmethanone).
  227         143. Pentedrone (alpha-Methylaminovalerophenone).
  228         144. Fluoroamphetamine.
  229         145. Fluoromethamphetamine.
  230         146. Methoxetamine.
  231         147. Methiopropamine.
  232         148. Methylbuphedrone (Methyl-alpha
  233  methylaminobutyrophenone).
  234         149. APB ((2-Aminopropyl)benzofuran).
  235         150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
  236         151. UR-144 (1-Pentyl-3-(2,2,3,3
  237  tetramethylcyclopropanoyl)indole).
  238         152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  239  tetramethylcyclopropanoyl)indole).
  240         153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  241  tetramethylcyclopropanoyl)indole).
  242         154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  243         155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  244  iodobenzoyl)indole).
  245         156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  246  carboxamide).
  247         157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
  248  cyclohexylcarbamate).
  249         158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
  250  cyclohexyl ester).
  251         159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
  252  benzoxazin-4-one).
  253         160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  254         161. 2C-H (2,5-Dimethoxyphenethylamine).
  255         162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  256         163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  257         164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  258  methoxybenzyl)]phenethylamine).
  259         165. MDMA (3,4-Methylenedioxymethamphetamine).
  260         166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  261         167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  262  carboxylate).
  263         168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  264  carboxylate).
  265         169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  266  3-carboxamide).
  267         170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  268  pentylindazole-3-carboxamide).
  269         171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  270  (4-fluorobenzyl)indazole-3-carboxamide).
  271         172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  272  1-pentylindazole-3-carboxamide).
  273         173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  274  yl)-1-(fluoropentyl)indole-3-carboxamide).
  275         174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  276  methoxybenzyl)]phenethylamine).
  277         175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  278  methoxybenzyl)]phenethylamine).
  279         176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  280  (cyclohexylmethyl)indazole-3-carboxamide).
  281         177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  282  carboxylate).
  283         178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  284  3-carboxamide).
  285         179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  286  (fluoropentyl)indazole-3-carboxamide).
  287         180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
  288         181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
  289  1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
  290         182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
  291  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  292  hexahydrobenzo[c]chromen-1-ol).
  293         183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
  294  (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
  295  hexahydrobenzo[c]chromen-1-ol).
  296         184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
  297  6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
  298  diol).
  299         185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
  300  dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
  301  tetrahydro-6aH-benzo[c]chromen-1-ol).
  302         186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
  303  6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
  304         187. MAPB ((2-Methylaminopropyl)benzofuran).
  305         188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
  306         189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
  307         190. Synthetic Cannabinoids.—Unless specifically excepted
  308  or unless listed in another schedule or contained within a
  309  pharmaceutical product approved by the United States Food and
  310  Drug Administration, any material, compound, mixture, or
  311  preparation that contains any quantity of a synthetic
  312  cannabinoid found to be in any of the following chemical class
  313  descriptions, or homologues, nitrogen-heterocyclic analogs,
  314  isomers (including optical, positional, or geometric), esters,
  315  ethers, salts, and salts of homologues, nitrogen-heterocyclic
  316  analogs, isomers, esters, or ethers, whenever the existence of
  317  such homologues, nitrogen-heterocyclic analogs, isomers, esters,
  318  ethers, salts, and salts of isomers, esters, or ethers is
  319  possible within the specific chemical class or designation.
  320  Since nomenclature of these synthetically produced cannabinoids
  321  is not internationally standardized and may continually evolve,
  322  these structures or the compounds of these structures shall be
  323  included under this subparagraph, regardless of their specific
  324  numerical designation of atomic positions covered, if it can be
  325  determined through a recognized method of scientific testing or
  326  analysis that the substance contains properties that fit within
  327  one or more of the following categories:
  328         a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
  329  naturally contained in a plant of the genus Cannabis, the
  330  synthetic equivalents of the substances contained in the plant
  331  or in the resinous extracts of the genus Cannabis, or synthetic
  332  substances, derivatives, and their isomers with similar chemical
  333  structure and pharmacological activity, including, but not
  334  limited to, Delta 9 tetrahydrocannabinols and their optical
  335  isomers, Delta 8 tetrahydrocannabinols and their optical
  336  isomers, Delta 6a,10a tetrahydrocannabinols and their optical
  337  isomers, or any compound containing a tetrahydrobenzo[c]chromene
  338  structure with substitution at either or both the 3-position or
  339  9-position, with or without substitution at the 1-position with
  340  hydroxyl or alkoxy groups, including, but not limited to:
  341         (I) Tetrahydrocannabinol.
  342         (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  343  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  344  ol).
  345         (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
  346  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
  347  ol).
  348         (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
  349  (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  350         (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
  351  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  352         (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
  353  2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  354         (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
  355  dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
  356         (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
  357  6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  358         (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
  359  6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  360         (X) Parahexyl.
  361         b. Naphthoylindoles, Naphthoylindazoles,
  362  Naphthoylcarbazoles, Naphthylmethylindoles,
  363  Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
  364  compound containing a naphthoylindole, naphthoylindazole,
  365  naphthoylcarbazole, naphthylmethylindole,
  366  naphthylmethylindazole, or naphthylmethylcarbazole structure,
  367  with or without substitution on the indole, indazole, or
  368  carbazole ring to any extent, whether or not substituted on the
  369  naphthyl ring to any extent, including, but not limited to:
  370         (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
  371         (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
  372  naphthoyl)indole).
  373         (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
  374         (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
  375         (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
  376         (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
  377         (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
  378         (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
  379         (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
  380         (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
  381         (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
  382         (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
  383         (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
  384         (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
  385  naphthoyl)indole).
  386         (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
  387         (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
  388         (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
  389  naphthoyl)indole).
  390         (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
  391         (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
  392         (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
  393         (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
  394         (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
  395  naphthylmethyl]indole).
  396         (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
  397  naphthoyl)indole).
  398         (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
  399  naphthoyl)indole).
  400         (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
  401  naphthoyl)indole).
  402         (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
  403         (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
  404         (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
  405         (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
  406         (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
  407         (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
  408  naphthoyl)indole).
  409         (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
  410  naphthoyl)indole).
  411         (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
  412  naphthoyl)indole).
  413         (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
  414  naphthoyl)indole).
  415         (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
  416  naphthoyl)indole).
  417         (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
  418         (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
  419  naphthoyl)indazole).
  420         (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
  421  naphthoyl)indole).
  422         (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
  423  naphthoyl)indole).
  424         (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
  425         (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1
  426  naphthoyl)carbazole).
  427         c. Naphthoylpyrroles.—Any compound containing a
  428  naphthoylpyrrole structure, with or without substitution on the
  429  pyrrole ring to any extent, whether or not substituted on the
  430  naphthyl ring to any extent, including, but not limited to:
  431         (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
  432         (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
  433         (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  434         (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  435         (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
  436         (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
  437  naphthoyl)pyrrole).
  438         (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
  439  naphthoyl)pyrrole).
  440         (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
  441  naphthoyl)pyrrole).
  442         (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
  443  naphthoyl)pyrrole).
  444         (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
  445  naphthoyl)pyrrole).
  446         d. Naphthylmethylenindenes.—Any compound containing a
  447  naphthylmethylenindene structure, with or without substitution
  448  at the 3-position of the indene ring to any extent, whether or
  449  not substituted on the naphthyl ring to any extent, including,
  450  but not limited to, JWH-176 (3-Pentyl-1
  451  (naphthylmethylene)indene).
  452         e. Phenylacetylindoles and Phenylacetylindazoles.—Any
  453  compound containing a phenylacetylindole or phenylacetylindazole
  454  structure, with or without substitution on the indole or
  455  indazole ring to any extent, whether or not substituted on the
  456  phenyl ring to any extent, including, but not limited to:
  457         (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
  458         (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
  459         (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
  460         (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
  461         (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
  462         (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
  463         (VII) Cannabipiperidiethanone.
  464         (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
  465  methoxyphenylacetyl)indole).
  466         f. Cyclohexylphenols.—Any compound containing a
  467  cyclohexylphenol structure, with or without substitution at the
  468  5-position of the phenolic ring to any extent, whether or not
  469  substituted on the cyclohexyl ring to any extent, including, but
  470  not limited to:
  471         (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
  472  yl)phenol).
  473         (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
  474  homologue).
  475         (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
  476  methyloctan-2-yl)phenol).
  477         g. Benzoylindoles and Benzoylindazoles.—Any compound
  478  containing a benzoylindole or benzoylindazole structure, with or
  479  without substitution on the indole or indazole ring to any
  480  extent, whether or not substituted on the phenyl ring to any
  481  extent, including, but not limited to:
  482         (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
  483         (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
  484         (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  485  iodo-5-nitrobenzoyl)indole).
  486         (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
  487  methoxybenzoyl)indole).
  488         (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
  489  iodobenzoyl)indole).
  490         (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
  491         (VII) RCS-4 C4 homologue (1-Butyl-3-(4
  492  methoxybenzoyl)indole).
  493         (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
  494  3-(4-methoxybenzoyl)indole).
  495         h. Tetramethylcyclopropanoylindoles and
  496  Tetramethylcyclopropanoylindazoles.—Any compound containing a
  497  tetramethylcyclopropanoylindole or
  498  tetramethylcyclopropanoylindazole structure, with or without
  499  substitution on the indole or indazole ring to any extent,
  500  whether or not substituted on the tetramethylcyclopropyl group
  501  to any extent, including, but not limited to:
  502         (I) UR-144 (1-Pentyl-3-(2,2,3,3
  503  tetramethylcyclopropanoyl)indole).
  504         (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
  505  tetramethylcyclopropanoyl)indole).
  506         (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
  507  tetramethylcyclopropanoyl)indole).
  508         (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
  509  tetramethylcyclopropanoyl)indole).
  510         (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
  511  tetramethylcyclopropanoyl)indole).
  512         (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
  513  tetramethylcyclopropanoyl)indole).
  514         (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
  515  tetramethylcyclopropanoyl)indole).
  516         (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
  517  tetramethylcyclopropanoyl)indazole).
  518         (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
  519  tetramethylcyclopropanoyl)indole).
  520         (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
  521  tetramethylcyclopropanoyl)indole).
  522         i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
  523  carboxamides, and Adamantylindazole carboxamides.—Any compound
  524  containing an adamantoyl indole, adamantoyl indazole, adamantyl
  525  indole carboxamide, or adamantyl indazole carboxamide structure,
  526  with or without substitution on the indole or indazole ring to
  527  any extent, whether or not substituted on the adamantyl ring to
  528  any extent, including, but not limited to:
  529         (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
  530         (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
  531  3-carboxamide).
  532         (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
  533  carboxamide).
  534         (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1
  535  adamantoyl)indole).
  536         (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
  537         (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
  538         (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1
  539  adamantoyl)indole).
  540         j. Quinolinylindolecarboxylates,
  541  Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
  542  and Quinolinylindazolecarboxamides.—Any compound containing a
  543  quinolinylindole carboxylate, quinolinylindazole carboxylate,
  544  isoquinolinylindole carboxylate, isoquinolinylindazole
  545  carboxylate, quinolinylindole carboxamide, quinolinylindazole
  546  carboxamide, isoquinolinylindole carboxamide, or
  547  isoquinolinylindazole carboxamide structure, with or without
  548  substitution on the indole or indazole ring to any extent,
  549  whether or not substituted on the quinoline or isoquinoline ring
  550  to any extent, including, but not limited to:
  551         (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
  552         (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
  553  carboxylate).
  554         (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
  555  carboxylate).
  556         (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
  557  carboxylate).
  558         (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
  559         (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
  560  3-carboxylate).
  561         (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
  562  3-carboxylate).
  563         (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
  564         (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
  565  carboxamide).
  566         k. Naphthylindolecarboxylates and
  567  Naphthylindazolecarboxylates.—Any compound containing a
  568  naphthylindole carboxylate or naphthylindazole carboxylate
  569  structure, with or without substitution on the indole or
  570  indazole ring to any extent, whether or not substituted on the
  571  naphthyl ring to any extent, including, but not limited to:
  572         (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
  573  carboxylate).
  574         (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
  575  carboxylate).
  576         (III) Fluoro SDB-005 (1-Naphthalenyl 1
  577  (fluoropentyl)indazole-3-carboxylate).
  578         (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
  579  carboxylate).
  580         (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
  581  carboxylate).
  582         l. Naphthylindole carboxamides and Naphthylindazole
  583  carboxamides.—Any compound containing a naphthylindole
  584  carboxamide or naphthylindazole carboxamide structure, with or
  585  without substitution on the indole or indazole ring to any
  586  extent, whether or not substituted on the naphthyl ring to any
  587  extent, including, but not limited to:
  588         (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
  589         (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
  590  3-carboxamide).
  591         (III) Chloro-NNEI (N-Naphthalen-1-yl 1
  592  (chloropentyl)indole-3-carboxamide).
  593         (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
  594  carboxamide).
  595         (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
  596  (fluoropentyl)indazole-3-carboxamide).
  597         m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
  598  indazole carboxamides, Alkylcarbonyl indole carboxylates, and
  599  Alkylcarbonyl indazole carboxylates.—Any compound containing an
  600  alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
  601  1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
  602  phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
  603  indole carboxamide, indazole carboxamide, indole carboxylate, or
  604  indazole carboxylate, with or without substitution on the indole
  605  or indazole ring to any extent, whether or not substituted on
  606  the alkylcarbonyl group to any extent, including, but not
  607  limited to:
  608         (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
  609  pentylindole-3-carboxamide).
  610         (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  611  yl)-1-(fluoropentyl)indole-3-carboxamide).
  612         (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  613  (fluoropentyl)indole-3-carboxamide).
  614         (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  615  pentylindazole-3-carboxamide).
  616         (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
  617  1-(fluoropentyl)indazole-3-carboxamide).
  618         (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
  619  1-pentylindazole-3-carboxamide).
  620         (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
  621  oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
  622         (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  623  (4-fluorobenzyl)indazole-3-carboxamide).
  624         (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  625  yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  626         (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
  627  (cyclohexylmethyl)indazole-3-carboxamide).
  628         (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  629  (cyclohexylmethyl)indazole-3-carboxamide).
  630         (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
  631  yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  632         (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  633  pentylindazole-3-carboxamide).
  634         (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
  635  (fluoropentyl)indazole-3-carboxamide).
  636         (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
  637  fluorobenzyl)indazole-3-carboxamide).
  638         (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  639  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
  640         (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  641  2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
  642         (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  643  2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
  644         (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  645  fluoropentyl)indole-3-carboxamide).
  646         (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
  647  fluoropentyl)indazole-3-carboxamide).
  648         (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
  649  (cyclohexylmethyl)indazole-3-carboxamide).
  650         (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
  651  fluorobenzyl)indazole-3-carboxamide).
  652         (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
  653  2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
  654         n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
  655  Any compound containing a N-(2-phenylpropan-2-yl) indole
  656  carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
  657  structure, with or without substitution on the indole or
  658  indazole ring to any extent, whether or not substituted on the
  659  phenyl ring of the cumyl group to any extent, including, but not
  660  limited to:
  661         (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
  662  carboxamide).
  663         (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
  664  (fluoropentyl)indole-3-carboxamide).
  665         o. Other Synthetic Cannabinoids.—Any material, compound,
  666  mixture, or preparation that contains any quantity of a
  667  Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
  668         (I) With or without modification or replacement of a
  669  carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
  670  between either two core rings, or linkage between a core ring
  671  and group structure, with or without the addition of a carbon or
  672  replacement of a carbon;
  673         (II) With or without replacement of a core ring or group
  674  structure, whether or not substituted on the ring or group
  675  structures to any extent; and
  676         (III) Is a cannabinoid receptor agonist, unless
  677  specifically excepted or unless listed in another schedule or
  678  contained within a pharmaceutical product approved by the United
  679  States Food and Drug Administration.
  680         191. Substituted Cathinones.—Unless specifically excepted,
  681  listed in another schedule, or contained within a pharmaceutical
  682  product approved by the United States Food and Drug
  683  Administration, any material, compound, mixture, or preparation,
  684  including its salts, isomers, esters, or ethers, and salts of
  685  isomers, esters, or ethers, whenever the existence of such salts
  686  is possible within any of the following specific chemical
  687  designations:
  688         a. Any compound containing a 2-amino-1-phenyl-1-propanone
  689  structure;
  690         b. Any compound containing a 2-amino-1-naphthyl-1-propanone
  691  structure; or
  692         c. Any compound containing a 2-amino-1-thiophenyl-1
  693  propanone structure,
  694  
  695  whether or not the compound is further modified:
  696         (I) With or without substitution on the ring system to any
  697  extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
  698  haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
  699  dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
  700  substituents;
  701         (II) With or without substitution at the 3-propanone
  702  position with an alkyl substituent or removal of the methyl
  703  group at the 3-propanone position;
  704         (III) With or without substitution at the 2-amino nitrogen
  705  atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
  706  not further substituted in the ring system; or
  707         (IV) With or without inclusion of the 2-amino nitrogen atom
  708  in a cyclic structure, including, but not limited to:
  709         (A) Methcathinone.
  710         (B) Ethcathinone.
  711         (C) Methylone (3,4-Methylenedioxymethcathinone).
  712         (D) 2,3-Methylenedioxymethcathinone.
  713         (E) MDPV (3,4-Methylenedioxypyrovalerone).
  714         (F) Methylmethcathinone.
  715         (G) Methoxymethcathinone.
  716         (H) Fluoromethcathinone.
  717         (I) Methylethcathinone.
  718         (J) Butylone (3,4-Methylenedioxy-alpha
  719  methylaminobutyrophenone).
  720         (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
  721         (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
  722         (M) Naphyrone (Naphthylpyrovalerone).
  723         (N) Bromomethcathinone.
  724         (O) Buphedrone (alpha-Methylaminobutyrophenone).
  725         (P) Eutylone (3,4-Methylenedioxy-alpha
  726  ethylaminobutyrophenone).
  727         (Q) Dimethylcathinone.
  728         (R) Dimethylmethcathinone.
  729         (S) Pentylone (3,4-Methylenedioxy-alpha
  730  methylaminovalerophenone).
  731         (T) Pentedrone (alpha-Methylaminovalerophenone).
  732         (U) MDPPP (3,4-Methylenedioxy-alpha
  733  pyrrolidinopropiophenone).
  734         (V) MDPBP (3,4-Methylenedioxy-alpha
  735  pyrrolidinobutyrophenone).
  736         (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
  737         (X) PPP (Pyrrolidinopropiophenone).
  738         (Y) PVP (Pyrrolidinovalerophenone) or
  739  (Pyrrolidinopentiophenone).
  740         (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
  741         (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
  742         (BB) F-MABP (Fluoromethylaminobutyrophenone).
  743         (CC) Me-EABP (Methylethylaminobutyrophenone).
  744         (DD) PBP (Pyrrolidinobutyrophenone).
  745         (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
  746         (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
  747         (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
  748         (HH) Dimethylone (3,4-Methylenedioxy-N,N
  749  dimethylcathinone).
  750         (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
  751         (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
  752         (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
  753         (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
  754         (MM) Methylbuphedrone (Methyl-alpha
  755  methylaminobutyrophenone).
  756         (NN) Methyl-alpha-methylaminohexanophenone.
  757         (OO) N-Ethyl-N-methylcathinone.
  758         (PP) PHP (Pyrrolidinohexanophenone).
  759         (QQ) PV8 (Pyrrolidinoheptanophenone).
  760         (RR) Chloromethcathinone.
  761         (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
  762         192. Substituted Phenethylamines.—Unless specifically
  763  excepted or unless listed in another schedule, or contained
  764  within a pharmaceutical product approved by the United States
  765  Food and Drug Administration, any material, compound, mixture,
  766  or preparation, including its salts, isomers, esters, or ethers,
  767  and salts of isomers, esters, or ethers, whenever the existence
  768  of such salts is possible within any of the following specific
  769  chemical designations, any compound containing a phenethylamine
  770  structure, without a beta-keto group, and without a benzyl group
  771  attached to the amine group, whether or not the compound is
  772  further modified with or without substitution on the phenyl ring
  773  to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
  774  halide, fused alkylenedioxy, fused furan, fused benzofuran,
  775  fused dihydrofuran, or fused tetrahydropyran substituents,
  776  whether or not further substituted on a ring to any extent, with
  777  or without substitution at the alpha or beta position by any
  778  alkyl substituent, with or without substitution at the nitrogen
  779  atom, and with or without inclusion of the 2-amino nitrogen atom
  780  in a cyclic structure, including, but not limited to:
  781         a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
  782         b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
  783         c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
  784         d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
  785         e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
  786         f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
  787         g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
  788         h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
  789         i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
  790         j. 2C-H (2,5-Dimethoxyphenethylamine).
  791         k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
  792         l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
  793         m. MDMA (3,4-Methylenedioxymethamphetamine).
  794         n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
  795  Methylenedioxy-N-methylbutanamine).
  796         o. MDA (3,4-Methylenedioxyamphetamine).
  797         p. 2,5-Dimethoxyamphetamine.
  798         q. Fluoroamphetamine.
  799         r. Fluoromethamphetamine.
  800         s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
  801         t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
  802         u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
  803         v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
  804         w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
  805         x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
  806         y. PMA (4-Methoxyamphetamine).
  807         z. N-Ethylamphetamine.
  808         aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
  809         bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
  810         cc. PMMA (4-Methoxymethamphetamine).
  811         dd. N,N-Dimethylamphetamine.
  812         ee. 3,4,5-Trimethoxyamphetamine.
  813         ff. 4-APB (4-(2-Aminopropyl)benzofuran).
  814         gg. 5-APB (5-(2-Aminopropyl)benzofuran).
  815         hh. 6-APB (6-(2-Aminopropyl)benzofuran).
  816         ii. 7-APB (7-(2-Aminopropyl)benzofuran).
  817         jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  818         kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  819         ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  820         mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
  821         nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
  822         oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
  823         pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
  824         qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
  825         rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
  826         ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
  827  dihydrobenzofuran),
  828  
  829  which does not include phenethylamine, mescaline as described in
  830  subparagraph 20., substituted cathinones as described in
  831  subparagraph 191., N-Benzyl phenethylamine compounds as
  832  described in subparagraph 193., or methamphetamine as described
  833  in subparagraph (2)(c)5.
  834         193. N-Benzyl Phenethylamine Compounds.—Unless specifically
  835  excepted or unless listed in another schedule, or contained
  836  within a pharmaceutical product approved by the United States
  837  Food and Drug Administration, any material, compound, mixture,
  838  or preparation, including its salts, isomers, esters, or ethers,
  839  and salts of isomers, esters, or ethers, whenever the existence
  840  of such salts is possible within any of the following specific
  841  chemical designations, any compound containing a phenethylamine
  842  structure without a beta-keto group, with substitution on the
  843  nitrogen atom of the amino group with a benzyl substituent, with
  844  or without substitution on the phenyl or benzyl ring to any
  845  extent with alkyl, alkoxy, thio, alkylthio, halide, fused
  846  alkylenedioxy, fused furan, fused benzofuran, or fused
  847  tetrahydropyran substituents, whether or not further substituted
  848  on a ring to any extent, with or without substitution at the
  849  alpha position by any alkyl substituent, including, but not
  850  limited to:
  851         a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
  852  methoxybenzyl)]phenethylamine).
  853         b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
  854  hydroxybenzyl)]phenethylamine).
  855         c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
  856  fluorobenzyl)]phenethylamine).
  857         d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
  858  methylenedioxybenzyl)]phenethylamine).
  859         e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
  860  methoxybenzyl)]phenethylamine).
  861         f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
  862  hydroxybenzyl)]phenethylamine).
  863         g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
  864  fluorobenzyl)]phenethylamine).
  865         h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
  866  methylenedioxybenzyl)]phenethylamine).
  867         i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
  868  methoxybenzyl)]phenethylamine).
  869         j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
  870  methoxybenzyl)]phenethylamine).
  871         k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
  872  methoxybenzyl)]phenethylamine).
  873         l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
  874  methoxybenzyl)]phenethylamine).
  875         m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
  876  hydroxybenzyl)]phenethylamine).
  877         n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
  878  fluorobenzyl)]phenethylamine).
  879         o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
  880  methylenedioxybenzyl)]phenethylamine).
  881         p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
  882  methoxybenzyl)]phenethylamine).
  883         q. 25H-NBOH (2,5-Dimethoxy-[N-(2
  884  hydroxybenzyl)]phenethylamine).
  885         r. 25H-NBF (2,5-Dimethoxy-[N-(2
  886  fluorobenzyl)]phenethylamine).
  887         s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
  888  methoxybenzyl)]phenethylamine),
  889  
  890  which does not include substituted cathinones as described in
  891  subparagraph 191.
  892         194. Substituted Tryptamines.—Unless specifically excepted
  893  or unless listed in another schedule, or contained within a
  894  pharmaceutical product approved by the United States Food and
  895  Drug Administration, any material, compound, mixture, or
  896  preparation containing a 2-(1H-indol-3-yl)ethanamine, for
  897  example tryptamine, structure with or without mono- or di
  898  substitution of the amine nitrogen with alkyl or alkenyl groups,
  899  or by inclusion of the amino nitrogen atom in a cyclic
  900  structure, whether or not substituted at the alpha position with
  901  an alkyl group, whether or not substituted on the indole ring to
  902  any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
  903  groups, including, but not limited to:
  904         a. Alpha-Ethyltryptamine.
  905         b. Bufotenine.
  906         c. DET (Diethyltryptamine).
  907         d. DMT (Dimethyltryptamine).
  908         e. MET (N-Methyl-N-ethyltryptamine).
  909         f. DALT (N,N-Diallyltryptamine).
  910         g. EiPT (N-Ethyl-N-isopropyltryptamine).
  911         h. MiPT (N-Methyl-N-isopropyltryptamine).
  912         i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
  913         j. 5-Hydroxy-N-methyltryptamine.
  914         k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
  915         l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
  916         m. Methyltryptamine.
  917         n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
  918         o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
  919         p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
  920         q. DiPT (N,N-Diisopropyltryptamine).
  921         r. DPT (N,N-Dipropyltryptamine).
  922         s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
  923         t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
  924         u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
  925         v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
  926         w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
  927         x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
  928         y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
  929  isopropyltryptamine).
  930         z. Methyl-alpha-ethyltryptamine.
  931         aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
  932  
  933  which does not include tryptamine, psilocyn as described in
  934  subparagraph 34., or psilocybin as described in subparagraph 33.
  935         195. Substituted Phenylcyclohexylamines.—Unless
  936  specifically excepted or unless listed in another schedule, or
  937  contained within a pharmaceutical product approved by the United
  938  States Food and Drug Administration, any material, compound,
  939  mixture, or preparation containing a phenylcyclohexylamine
  940  structure, with or without any substitution on the phenyl ring,
  941  any substitution on the cyclohexyl ring, any replacement of the
  942  phenyl ring with a thiophenyl or benzothiophenyl ring, with or
  943  without substitution on the amine with alkyl, dialkyl, or alkoxy
  944  substituents, inclusion of the nitrogen in a cyclic structure,
  945  or any combination of the above, including, but not limited to:
  946         a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
  947  (Benocyclidine).
  948         b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
  949  of phencyclidine).
  950         c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
  951  analog of phencyclidine).
  952         d. PCPr (Phenylcyclohexylpropylamine).
  953         e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
  954  analog of phencyclidine).
  955         f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
  956         g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
  957         h. Methoxetamine.
  958         i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
  959         j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
  960         k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
  961         l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
  962         m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
  963         n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
  964         o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
  965         p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
  966         q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
  967         r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
  968         196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
  969  piperidinylidene]-benzenesulfonamide.
  970         197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
  971  piperidinylidene]-benzenesulfonamide.
  972         198. AH-7921, 3,4-dichloro-N-[[1
  973  (dimethylamino)cyclohexyl]methyl]-benzamide.
  974         199. U47700, trans-3,4-dichloro-N-[2
  975  (dimethylamino)cyclohexyl]-N-methyl-benzamide.
  976         200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
  977  dihydrochloride.
  978         Section 2. This act shall take effect July 1, 2024.

feedback